- Home
- COSM vs IBIO Comparison
COSM vs IBIO Comparison
Compare COSM & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- IBIO
- Stock Information
- Founded
- COSM 2009
- IBIO 2008
- Country
- COSM United States
- IBIO United States
- Employees
- COSM N/A
- IBIO N/A
- Industry
- COSM Other Pharmaceuticals
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- IBIO Health Care
- Exchange
- COSM Nasdaq
- IBIO Nasdaq
- Market Cap
- COSM 8.2M
- IBIO 9.3M
- IPO Year
- COSM 2013
- IBIO N/A
- Fundamental
- Price
- COSM $0.48
- IBIO $0.98
- Analyst Decision
- COSM
- IBIO Strong Buy
- Analyst Count
- COSM 0
- IBIO 3
- Target Price
- COSM N/A
- IBIO $4.87
- AVG Volume (30 Days)
- COSM 356.0K
- IBIO 452.8K
- Earning Date
- COSM 05-15-2025
- IBIO 05-02-2025
- Dividend Yield
- COSM N/A
- IBIO N/A
- EPS Growth
- COSM N/A
- IBIO N/A
- EPS
- COSM N/A
- IBIO N/A
- Revenue
- COSM $53,554,457.00
- IBIO $375,000.00
- Revenue This Year
- COSM $28.14
- IBIO $36.00
- Revenue Next Year
- COSM N/A
- IBIO N/A
- P/E Ratio
- COSM N/A
- IBIO N/A
- Revenue Growth
- COSM N/A
- IBIO 650.00
- 52 Week Low
- COSM $0.28
- IBIO $0.64
- 52 Week High
- COSM $1.58
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- COSM 57.76
- IBIO 48.45
- Support Level
- COSM $0.44
- IBIO $0.75
- Resistance Level
- COSM $0.50
- IBIO $1.03
- Average True Range (ATR)
- COSM 0.04
- IBIO 0.08
- MACD
- COSM 0.00
- IBIO 0.08
- Stochastic Oscillator
- COSM 75.00
- IBIO 75.74
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.